Apellis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
CEOCedric Francois
CEOCedric Francois
Employees710
Employees710
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2009
Founded2009
Employees710
Employees710
APLS Key Statistics
Market cap3.19B
Market cap3.19B
Price-Earnings ratio85.25
Price-Earnings ratio85.25
Dividend yield—
Dividend yield—
Average volume2.42M
Average volume2.42M
High today$25.95
High today$25.95
Low today$25.02
Low today$25.02
Open price$25.04
Open price$25.04
Volume3.10M
Volume3.10M
52 Week high$35.71
52 Week high$35.71
52 Week low$16.10
52 Week low$16.10
Stock Snapshot
Apellis Pharmaceuticals(APLS) stock is priced at $25.11, giving the company a market capitalization of 3.19B. It carries a P/E multiple of 85.25.
During the trading session on 2025-12-17, Apellis Pharmaceuticals(APLS) shares reached a daily high of $25.95 and a low of $25.02. At a current price of $25.11, the stock is +0.4% higher than the low and still -3.2% under the high.
Trading activity shows a volume of 3.1M, compared to an average daily volume of 2.42M.
The stock's 52-week range extends from a low of $16.10 to a high of $35.71.
The stock's 52-week range extends from a low of $16.10 to a high of $35.71.
Analyst ratings
60%
of 20 ratingsBuy
60%
Hold
35%
Sell
5%
People also own
Based on the portfolios of people who own APLS. This list is generated using Robinhood data, and it’s not a recommendation.